Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-release Quetiapine in Relapsing-remitting and Progressive Multiple Sclerosis
NCT02087631Phase 2Completed
- Sponsor
- University of Calgary
- Start
- Dec 2014
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quetiapine in multiple sclerosis (MS), sponsored by University of Calgary. Started Dec 2014; status: completed.
02
Drugs
quetiapine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02087631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02087631.